Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Chinese Patent Office
UBS
Healthtrust
Baxter
Argus Health
Fuji
Accenture
Express Scripts

Generated: June 22, 2018

DrugPatentWatch Database Preview

IBUPROFEN SODIUM Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

When do Ibuprofen Sodium patents expire, and when can generic versions of Ibuprofen Sodium launch?

Ibuprofen Sodium is a drug marketed by Perrigo R And D and is included in one NDA.

The generic ingredient in IBUPROFEN SODIUM is ibuprofen sodium. There are sixty-four drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the ibuprofen sodium profile page.
Drug patent expirations by year for IBUPROFEN SODIUM
Synonyms for IBUPROFEN SODIUM
15687-27-1 (Parent)
2-(p-isobutylphenyl)propionic acid sodium salt
31121-93-4
5264-06-2
AC1NSQTG
AC1Q1V4C
AK128321
AKOS015994627
Ambcb5264062
Benzeneacetic acid, alpha-methyl-4-(2-methylpropyl)-, sodium salt
Benzeneacetic acid, alpha-methyl-4-(2-methylpropyl)-, sodium salt (9CI)
BIM-0005680.P001
C13H17O2.Na
CB08098
CHEMBL1241153
CTK4J6221
D08059
DTXSID4040501
EINECS 250-477-6
Esprenit (TN)
HS-0087
Hydratropic acid, p-isobutyl-, sodium salt
Ibuprofen sodium anhydrous
Ibuprofen sodium salt
Ibuprofen, Sodium Salt
IBUPROFENSODIUMSALT
KS-00002WUJ
LS-76355
MFCD00133414
MolPort-000-563-213
OR011634
OR256383
p-Isobutylhydratropic acid sodium salt
PTTPUWGBPLLBKW-UHFFFAOYSA-M
SCHEMBL139269
SMSF0005424
Sodium 2-(4-isobutylphenyl)propanoate
Sodium 2-(4-isobutylphenyl)propionate
sodium 2-(4'-isobutylphenyl)propionate
sodium 2-[4-(2-methylpropyl)phenyl]propanoate
Sodium ibuprofen
sodium ibuprofen salt
SODIUM P-ISOBUTYLHYDRATROPATE
W-110791

US Patents and Regulatory Information for IBUPROFEN SODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Perrigo R And D IBUPROFEN SODIUM ibuprofen sodium TABLET;ORAL 206581-001 Aug 3, 2015 OTC No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
US Army
Deloitte
Teva
Accenture
Queensland Health
Federal Trade Commission
Dow
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.